These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9812142)

  • 21. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 24. Aggressive behaviour associated with donepezil treatment: a case report.
    Bianchetti A; Trabucchi M; Cipriani G
    Int J Geriatr Psychiatry; 2003 Jul; 18(7):657-8. PubMed ID: 12833312
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraoperative floppy-iris syndrome associated with chronic intake of donepezil.
    Papadopoulos R; Bachariou A
    J Cataract Refract Surg; 2007 Nov; 33(11):1997-8. PubMed ID: 17964415
    [No Abstract]   [Full Text] [Related]  

  • 26. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
    Wolff ML
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil and cardiac syncope: case report.
    Jane Newby V; Anne Kenny R; McKeith IG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
    [No Abstract]   [Full Text] [Related]  

  • 28. Donepezil for severe Alzheimer's disease.
    Opie LH
    Lancet; 2006 Jul; 368(9533):361-2; author reply 362. PubMed ID: 16876651
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents.
    Burt T
    Curr Psychiatry Rep; 2000 Dec; 2(6):473-8. PubMed ID: 11122998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
    Hegerl U; Mergl R; Henkel V; Gallinat J; Kotter G; Müller-Siecheneder F; Pogarell O; Juckel G; Schröter A; Bahra R; Emir B; Laux G; Möller HJ
    J Clin Psychopharmacol; 2003 Apr; 23(2):214-6. PubMed ID: 12640228
    [No Abstract]   [Full Text] [Related]  

  • 34. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroleptic malignant-like syndrome due to donepezil and maprotiline.
    Ohkoshi N; Satoh D; Nishi M; Shoji S
    Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986
    [No Abstract]   [Full Text] [Related]  

  • 36. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrence of upper gastrointestinal bleeding after donepezil administration.
    Cholongitas E; Pipili C; Dasenaki M
    Alzheimer Dis Assoc Disord; 2006; 20(4):326. PubMed ID: 17132985
    [No Abstract]   [Full Text] [Related]  

  • 38. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
    Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
    Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Alzheimer drugs (donepezil).
    Smith Doody R
    Neurologist; 2003 Sep; 9(5):225-9. PubMed ID: 12971832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advertisements for donepezil (Aricept) in the BMJ. Local committee has declined to approve NHS hospital prescription of donepezil.
    Wagner N
    BMJ; 1997 May; 314(7093):1555-6. PubMed ID: 9183223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.